Skip navigation
Search
Sciety application settings
Home
Groups
Explore
Newsletter
About
Log In
Sign Up
LAT4 drives temozolomide induced radiotherapy resistance in glioblastoma by enhancing mTOR pathway activation
Wenrui Zang
Yangwu Liu
Jiajun Zheng
Yifeng Huang
Lei Chen
Chiyang Li
Jiakun Zhao
Qiang Zhou
Yangheng Xu
Zhenyuan Wang
Yongfu Cao
Wanling Zhang
Junjie Li
Yuntao Lu
Read the full article
See related articles
Listed in
This article is not in any list yet, why not save it to one of your lists.
Log in to save this article
Abstract
No abstract available
Article activity feed
Version published to 10.1186/s12935-024-03590-0
Dec 18, 2024
Version published to 10.21203/rs.3.rs-4913708/v1 on Research Square
Oct 14, 2024
Related articles
BRD4 inhibition sensitizes glioblastoma to radiotherapy by suppressing super-enhancer-driven COL1A1
This article has 9 authors:
Jiajia Chen
Xichen Fan
Yi Yang
Xuenan Li
Li Yu
Yafei Wang
Ziheng Wang
Shubao Wang
Weichen Duan
PRMT5 inhibition sensitizes glioblastoma tumor models to temozolomide
This article has 22 authors:
Shumpei Onishi
Sridharan Jayamohan
Ashis Chowdhury
Sarah Rivas
Yoshihiro Otani
Sara A. Murphy
Kimberly A. Rivera-Caraballo
Stuart Walbridge
Ashish H. Shah
Bayu Sisay
Dragan Maric
Abdel Elkahloun
Kory Johnson
John Heiss
Tae Jin Lee
Sangamesh G. Kumbar
Desmond A. Brown
Ji Young Yoo
Andrew Brenner
Balveen Kaur
Gangadhara R. Sareddy
Yeshavanth Kumar Banasavadi-Siddegowda
Proinflammatory macrophage-derived medium enhances temozolomide sensitivity in glioblastoma via pSTAT3-mediated downregulation of DNA repair enzymes
This article has 10 authors:
Susana López-López
Beatriz Castro-Robles
María José M. Díaz‐Guerra
Lourdes Arias-Salazar
Hernán Sandoval
Daniel García-Pérez
Christoph J. Klein-Zampaña
Rosa A Barbella-Aponte
Tomás Segura
Gemma Serrano-Heras
Site navigation links
Home
Groups
Explore
Newsletter
About
Log In
Sign Up